Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 51655-519

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 51655-519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 519 26)

Label (51655 519 26)
NDC: 51655-519-26 Metoprolol Succinate Extended-Release Tablets, USP 50mg with 90 tablets per container, is a prescription drug that should be stored at 25°C (77°F) with excursions permitted to 75°-30°C (55°-86°F) in the original container only. Each film-coated tablet contains 47.5mg of metoprolol succinate, USP equivalent to 50mg of metoprolol tartrate, USP. This drug is manufactured by Teva Pharmaceuticals USA, Inc. and repackaged by Northwind Pharmaceuticals, Indianapolis, IN 46203 with an LCN# of 00 and a Rev. A 12122. The GTIN is 0351655519264 and the Lot is 0000000000. Dosage instructions are found on the package insert and this medication should be kept away from children.*
FDA Label Image

Image (Image 10)

Image (Image 10)
FDA Label Image

2 (Image 5)

2 (Image 5)
FDA Label Image

1 (Image 6)

1 (Image 6)
Results for Subgroups in MERIT-HF are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.